Free Access
Med Sci (Paris)
Volume 22, Number 2, Février 2006
Page(s) 192 - 196
Section M/S revues
Published online 15 February 2006
  1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105 : 3768–85. [Google Scholar]
  2. Bagot M, Echchakir H, Mami-Chouaib F, et al. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T cell clones infiltrating a cutaneous T cell lymphoma. Blood 1998; 91 : 4331–41. [Google Scholar]
  3. Dalloul A, Laroche L, Bagot M, et al. Interleukin-7 is a growth factor for Sezary lymphoma cells. J Clin Invest 1992; 90 : 1054–60. [Google Scholar]
  4. Bagot M, Charue D, Boulland ML, et al. Interleukin-7 receptor expression in cutaneous T-cell lymphomas. Br J Dermatol 1996; 135 : 572–5. [Google Scholar]
  5. Rich BE, Campos-Torres J, Tepper RI, et al. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J Exp Med 1993; 177 : 305–16. [Google Scholar]
  6. Williams IR, Rawson EA, Manning L, et al. IL-7 overexpression in transgenic mouse keratinocytes causes a lymphoproliferative skin disease dominated by intermediate TCR cells : evidence for a hierarchy in IL-7 responsiveness among cutaneous T cells. J Immunol 1997; 159 : 3044–56. [Google Scholar]
  7. Poszepczynska E, Bagot M, Echchakir H, et al. Functional characterization of an IL-7 dependent CD4+CD8alpha+ Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma. Blood 2000; 96 : 1056–63. [Google Scholar]
  8. Michel L, Dupuy A, Jean-Louis F, et al. Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells : evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C). J Invest Dermatol 2003; 121 : 881–93. [Google Scholar]
  9. Edelman J, Meyerson HJ. Diminished CD3 expression is useful for detecting and enumerating Sezary cells. Am J Clin Pathol 2000; 114 : 467–77. [Google Scholar]
  10. Laetsch B, Haffner AC, et al. CD4+/CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol 2000; 114 : 107–11. [Google Scholar]
  11. Bernengo MG, Novelli M, Quaglino P, et al. The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells. Br J Dermatol 2001; 144 : 125–35. [Google Scholar]
  12. Dereure O, Portales P, Clot J, Guilhou JJ. Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas. Br J Dermatol 2000; 143 : 1205–10. [Google Scholar]
  13. Pende D, Biassoni R, Cantoni C, et al. The natural killer cell receptor specific for HLA-A allotypes : a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996; 184 : 505–18. [Google Scholar]
  14. Moretta A, Biassoni R, Bottino C, et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997; 155 : 105–17. [Google Scholar]
  15. Bagot M, Moretta A, Sivori S, et al. CD4+ cutaneous T cell lymphoma cells express the p140/killer cell immunoglobulin-like receptor. Blood 2001; 97 : 1388–91. [Google Scholar]
  16. Wechsler J, Bagot M, Nikolova M, et al. Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes. J Pathol 2003; 199 : 77–83. [Google Scholar]
  17. Poszepczynska-Guigné E, Schiavon V, D’Incan M, et al. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells : relevance for the diagnostic and follow-up of Sezary syndrome. J Invest Dermatol 2004; 122 : 820–3. [Google Scholar]
  18. Nikolova M, Musette P, Bagot M, et al. Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling. Blood 2002; 100 : 1019–25. [Google Scholar]
  19. Bagot M, Nikolova M, Schirm-Chabanette F, et al. Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas. Ann NY Acad Sci 2001; 941 : 31–8. [Google Scholar]
  20. Nikolova M, Tawab A, Marie-Cardine A, et al. Increased expression of a novel early activation surface membrane receptor in cutaneous T cell lymphoma cells. J Invest Dermatol 2001; 116 : 731–8. [Google Scholar]
  21. Echchakir H, Bagot M, Dorothee G, et al. Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. J Invest Dermatol 2000; 115 : 74–80. [Google Scholar]
  22. Berger CL, Tigelaar R, Cohen J, et al. Cutaneous T-cell lymphoma : malignant proliferation of T regulatory cells. Blood 2005; 105 : 1640–7. [Google Scholar]
  23. Yawalkar N, Ferenczi K, Jones DA, et al. Profound loss of T cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood 2003; 102 :4059–66. [Google Scholar]
  24. Muche M, Karenko L, Gellrich S, et al. Cellular coincidence of clonal T cell receptor rearrangements and complex clonal chromosomal aberrations. A hallmark of malignancy in cutaneous T cell lymphoma. J Invest Dermatol 2004; 122 : 574–8. [Google Scholar]
  25. Mao X, Orchard G, Lillington DM, et al. BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Br J Dermatol 2004; 151 : 546–56. [Google Scholar]
  26. Van Doorn R, Dijkman R, Vermeer MH, et al. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res 2004; 64 : 5578–86. [Google Scholar]
  27. Su MW, Dorocicz I, Dragowska WH, et al. Aberrant expression of T-plastin in Sezary cells. Cancer Res 2003; 63 : 7122–7. [Google Scholar]
  28. Tracey L, Villuendas R, Ortiz P, et al. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol 2002; 161 : 1825–37. [Google Scholar]
  29. Kari L, Loboda A, Nebozhyn M, et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 2003; 197 : 1477–88. [Google Scholar]
  30. Tracey L, Villuendas R, Dotor AM, et al. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway : an expression profile study. Blood 2003; 102 : 1042–50. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.